Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors?

Allogeneic hematopoietic cell transplantation (allo-HCT) and chimeric antigen receptor T cell (CAR T) therapy are the main modalities of adoptive cellular immunotherapy that have widely permeated the clinical space. The advent of both technologies revolutionized treatment of many hematologic maligna...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldsmith, Scott R., Ghobadi, Armin, DiPersio, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783412/
https://www.ncbi.nlm.nih.gov/pubmed/33415078
http://dx.doi.org/10.3389/fonc.2020.608916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783412/
https://www.ncbi.nlm.nih.gov/pubmed/33415078
http://dx.doi.org/10.3389/fonc.2020.608916

Ejemplares similares